Pharmyn ApS: Financial statements 2019
CVR: 37133892
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 108 and a net result of DKK 0 compared with DKK 88 the year before. That is a decrease of 62.5% compared with the year before. Equity in the 2019 report amounted to DKK 42,379. The solvency ratio was 84%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 108
- Profit/Loss
- DKK 0
- Equity
- DKK 42,379
- Total Assets
- DKK 50,479
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 108 | 0 | 42 t. | 1 |
| 2018 | - | 288 | 88 | 42 t. | 0 |
| 2017 | - | -4 t. | -4 t. | 42 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Pharmyn ApS has published its annual report for 2018. Gross profit came to DKK 288, and the net result was DKK 88.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.